The relatively rare entity pyothorax-associated lymphoma (PAL) is an aggressive disease with a poor prognosis. Therefore, PAL should be diagnosed as soon as possible with minimal invasion. We herein report the case of an 81-year-old man with PAL that was successfully treated with chemotherapy. A computed tomography-guided tumor biopsy could not provide adequate specimens for pathological investigation, whereas a diffusion-weighted magnetic resonance imaging-guided tumor biopsy led to a diagnosis. Our findings suggest that diffusion-weighted image guidance for planning the biopsy of an intrathoracic mass, especially in cases of suspected PAL, is a highly accurate method because it provides information about cellularity and does not create calcification-related artifacts.
Introduction
The relatively rare entity pyothorax-associated lymphoma (PAL) was first reported in Japan in 1987 (1) . Almost all cases of PAL have occurred in Japan, with sporadic cases in Western countries. PAL is a distinct type of malignant lymphoproliferative disease, most commonly a diffuse large Bcell lymphoma associated with chronic inflammation and Epstein-Barr virus (EBV) infection (2) . PAL develops in chronically inflamed tissue of the pyothorax after artificial pneumothorax for treatment of pulmonary tuberculosis and tuberculous pleurisy (2) . Its duration of onset is long; the median interval between onset of pyothorax and diagnosis of PAL has been reported as 43 years (range 19-64 years) (3) . Although a recent study showed that combination chemotherapy and radiation therapies were effective, the standard management strategy for PAL has not been established. The overall prognosis of PAL remains poor because of its aggressive nature and poor performance status and the advanced age and multiple comorbidities of PAL patients (2, 3) . Therefore, to initiate appropriate treatment, we should diagnose PAL in a less invasive and more expeditious manner. We herein report the first case of a patient with PAL that was pathologically confirmed by diffusionweighted magnetic resonance imaging (DW-MRI)-guided needle biopsy, suggesting the usefulness of DW-MRI guidance for biopsy. Figure 1 . A computed tomography scan of the chest on admission shows a large mass adjacent to the pyothorax that is surrounded by calcification and directly invades the vertebral bodies. An artifact caused by the calcification surrounding the pyothorax is seen in the lesion (black arrow). A percutaneous needle tumor biopsy was taken from the right lateral edge of the tumor on the day of admission (star).
ranges. A physical examination revealed dull to percussion and decreased vesicular breath sounds in the right lower posterior chest. There was no palpable lymphadenopathy or hepatosplenomegaly. Computed tomography (CT) scans of the chest revealed a large tumor adjacent to the pyothorax that was surrounded by calcification and directly invaded the vertebral bodies (Fig. 1) . The laboratory tests revealed microcytic anemia, a red blood cell count of 363×10 4 /μL, a hemoglobin level of 9.2 g/dL, a hematocrit level of 28.7% and elevated levels of lactate dehydrogenase (LDH, 288 IU/L), alkaline phosphatase (ALP, 1,683 IU/L), C-reactive protein (CRP, 15.49 mg/dL) and soluble interleukin-2 receptors (sIL-2Rs, 1,517 U/mL).
Guided by CT, a percutaneous needle biopsy was taken from the right lateral edge of the tumor on the day of admission (Fig. 1) . Histopathological examination of this specimen showed only necrotic tissue. Magnetic resonance imaging (MRI) was then performed using a 1.5T MR scanner (GE Signa HDxt 1.5 T, GE Healthcare, Little Chalfont, UK), and diffusion-weighted/T2-weighted magnetic resonance images were fused using the Philips Extended MR Work Space 2.6.3.4 (Philips Medical Systems, Veenpluis, The Netherlands) ( Fig. 2A) . Five days after the first tumor biopsy, a second needle biopsy was taken with the needle tip directed at the region showing high signal intensity on the fusion image, which was closer to the posterior surface of the body than the first biopsied site (Fig. 2B) .
Histopathological examination of the second tumor biopsy revealed a diffuse proliferation of medium to large atypical lymphoid cells with round to ovoid large nucleoli, sometimes irregular in shape (Fig. 3A) . Immunohistochemistry of the lymphocytic cells in the tumor biopsy showed positivity for leukocyte common antigen (LCA), CD79a, paired box gene-5 and CD2, and negativity for CD3, CD4, CD5, CD10, CD20, CD138 and ubiquitin carboxyl-terminal esterase L1 (UCHL-1) ( Fig. 3B-E ; data for LCA, CD2, CD4, CD10, CD138 and UCHL-1 are not shown). Eighty to ninety percent of the tumor cells expressed mindbomb homolog 1 (MIB 1) (data not shown). In situ hybridization showed robust expression of EBV-encoded small mRNA (EBER) (Fig. 3F) , EBV late membrane protein-1 (LMP-1) and EBV nuclear antigen-2 (EBNA-2) (data not shown), suggesting EBV latency type III.
Further investigations were performed. A bone marrow aspiration and biopsy showed no evidence of lymphomatous infiltration. Contrast-enhanced CT showed a necrotic area in the tumor (Fig. 4A) , and fluorodeoxyglucose positron emission tomography-CT (FDG PET-CT) suggested strong hypermetabolic involvement (standard uptake value max = 17.1) in the tumor except in the necrotic area (Fig. 4B) . Neither method detected metastatic lesions. Serological tests revealed a past infection pattern in anti-EBV antibody titers as follows: anti-viral capsid antigen (VCA)-IgG = 640, anti-VCA-IgA <10, anti-VCA-IgM <10 and anti-EBV nuclear antigen = 160.
On the basis of these findings, a diagnosis of diffuse large B-cell lymphoma associated with chronic inflammation, also known as PAL, was made. The patient experienced unexplained fever, chills and fatigue after admission. The European Cooperative Oncology Group (ECOG) performance status, clinical stage and International Prognostic Index were grade 2, IEB, and high-intermediate risk, respectively.
After the diagnosis, the patient received combination chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine and prednisolone, which was tolerated very well. The five treatment cycles administered thus far produced clinical responses including relief of back pain and Bsymptoms, a significant reduction in tumor size as determined via CT and more normal levels of LDH, ALP, CRP and sIL-2R in serological tests.
Discussion
In the present case, PAL associated with EBV latency type III infection was diagnosed on the basis of the histopathology and immunohistochemistry of DW-MRI-guided percutaneous needle biopsies. Latent infection with EBV, an oncogenic human herpesvirus, is known to be associated with various malignancies. There are three types of latent infection (types I-III) as categorized via viral latent gene expression patterns. EBV can transform B-cells into immortalized lymphoblastoid cells with type III latency, in which all latent genes are expressed, as in the present case. B-cell transformation and immortalization play a central role in EBV-associated lymphoproliferative disorders in immunocompromised individuals, including those with PAL.
In recent years, due to the establishment of personalized medicine, oncological management and treatment have been advanced and become individualized along with the development of numerous anti-cancer agents based on molecular profiles and targeted therapy. Therefore, it is important to collect adequate amounts of tumor cells and/or tissue for histopathological and molecular biological assessment. Im- aging studies using CT and ultrasound sonography play an important role in determining the sites for biopsies of chest lesions. Today, a percutaneous needle biopsy is commonly guided by CT or ultrasound, and its safety and usefulness are widely recognized.
Until very recently, DW-MRI was only used to evaluate intracranial diseases. Its application to extracranial, especially intrathoracic, lesions was technically problematic and not always practicable because of the high number of artifacts resulting from physiologic motions such as breathing and heart pulsation (4). However, with advances in MRI techniques, DW-MRI can currently be applied to extracranial lesions such as those located in the trunk and especially in the abdomen and pelvis (5) . To date, this technique has been used to characterize, grade and stage intrathoracic lesions such as lung tumors and mediastinal masses, as well as to differentiate central tumors from post-obstructive atelectasis (6) . It is beginning to be used for the staging and response assessment of lymphomas (7) (8) (9) (10) . Because DW-MRI of extracranial lesions has only just begun, there are only a few reports about its usefulness for evaluating pleural disease (11, 12) and identifying appropriate areas for biopsies of intrathoracic lesions (13, 14) . There are no reports about its usefulness for determining optimum biopsy sites of pleural disease.
In the present case, tumor biopsies were performed in two different areas, the first selected by CT and the second by DW-MRI. The first biopsy was uninformative because the specimens contained only necrotic tissue. Retrospectively, the first biopsied area had a lower signal intensity in DW-MRI than did other areas of the lesion. Conversely, the second biopsy was taken from an area with a high signal intensity in DW-MRI, and it provided adequate specimens for analysis. This finding suggests that DW-MRI has some advantages over other modalities for evaluating lesions and selecting optimum biopsy areas in PAL patients.
MRI can detect anatomical and morphological differences between soft tissues and organs in detail. DW-MRI can provide additional information about the degree of tissue cellularity and the integrity of cellular membranes (15) . Many malignant tumors, including lymphomas, often consist of tissues with a high density of atypical cells with intact membranes (15) . As shown in our study, DW-MRI can distinguish cell-rich, high activity regions from regions with low cellularity in necrotic areas of the tumor and surrounding normal tissue. Therefore, the areas showing high signal intensity on DW-MRI should be biopsied for high diagnostic accuracy.
Contrast-enhanced CT provides image contrast dependent on tissue vascularity and can indicate areas inappropriate for biopsy, such as intratumoral necrotic areas. However, it is not a functional imaging method and cannot select the areas with the highest cellularity. Additional disadvantages are radiation exposure, calcification artifacts and the need to use contrast media, which is discouraged in elderly populations where the likelihood of kidney injury is high. Calcification does not create artifacts in magnetic resonance images as it does in CT images. In the present case, the optimum biopsy area indicated by DW-MRI and FDG PET-CT appears as a low-density area on non-contrast and contrast-enhanced CT because of artifacts caused by pleural calcification. Hence, this area was not selected for the first biopsy. In PAL, minimizing the number of calcification artifacts is particularly important because PAL always develops in the pleura of the pyothorax, which is often surrounded by calcification.
FDG PET-CT is an alternative functional imaging method to DW-MRI. Its efficacy in determining the clinical stage at diagnosis and response after therapy has been validated, and it is thought to be a good modality for choosing biopsy areas (16, 17) . Additional advantages are no calcification artifacts and no need to use contrast media. Its disadvantages are the rarity and high cost of PET/CT scanners and the risks of ionizing radiation exposure. Furthermore, it requires more time for patient examination than does DW-MRI and the findings are confounded by hyperglycemia, a frequent characteristic of elderly populations where the prevalence of diabetes is high.
Compared with FDG PET-CT and contrast-enhanced CT, the advantages of DW-MRI are the readily accessible equipment, the affordability of equipment, a shorter procedure and the elimination of calcification artifacts, the risks of radiation exposure and the use of contrast media. Therefore, in the initial assessment of pleural masses with minimum invasion, CT, DW-MRI and FDG PET-CT provide different information: tumor presence, the optimum biopsy areas and the initial clinical stage after the diagnosis of malignant disease, respectively.
In conclusion, DW-MRI is a useful technique for the planning of the biopsy of intrathoracic pleural masses, especially in cases of suspected PAL. It provides high diagnostic accuracy based on cellularity and does not create calcification artifacts. At the dawn of a new era in DW-MRI application to extracranial lesions, further research is needed to confirm its efficacy in practical use.
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